ISDA

Deposition Date 2022-05-24

Release Date 2023-06-07

Last Version Date 2024-10-23

Entry Detail

PDB ID:

8CZ8

Keywords:

ANTITUMOR PROTEIN

Title:

Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Homo sapiens

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.60 Å

R-Value Free:

0.22

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 32

Download Validation Report

Macromolecular Entities

Polymer Type:polypeptide(L)
Molecule:scFv Anetumab
Chain IDs:A (auth: C), E (auth: A)
Chain Length:247
Number of Molecules:2
Biological Source:Homo sapiens

Polymer Type:polypeptide(L)
Molecule:scFv of A12 anti-mesothelin antibody
Chain IDs:D, F (auth: B)
Chain Length:242
Number of Molecules:2
Biological Source:Homo sapiens

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mesothelin, cleaved form
Gene (Uniprot):MSLN
Chain IDs:B (auth: M), C (auth: E)
Chain Length:159
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q13421

Ligand Molecules

SO4

Primary Citation

Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics

Lin, I, Rupert, P.B, Pilat, K, Ruff, R.O, Friend, D.J, Chan, M.K, Clarke, M, Hoffstrom, B.G, Carter, J, Meshinchi, S, Bandaranayake, A.D, Mehlin, C, Olson, J.M, Strong, R.K, Correnti, C.E.Show

Front. Drug Discov. 3 ? ? (2023)

DOI: 10.3389/fddsv.2023.1216516

Primary Citation of related structures